GSK to buy US cancer treatment firm Nuvalent for $10.6bn

Sanatate

British drugmaker’s new chief executive Luke Miels announces one of its biggest deals Business live – latest updates British drugmaker’s new chief executive Luke Miels announces one of its biggest deals Business live – latest updates GSK’s new boss Luke Miels has struck one of the British drugmaker’s biggest deals, announcing the $10.6bn (£7.9bn) acquisition of a US cancer specialist with two-late stage medications. The FTSE 100 company is boosting its oncology portfolio by agreeing to buy

Tag-uri: GSK

GSK to buy US cancer treatment firm Nuvalent for $10.6bn https://www.theguardian.com - 09.06.2026 09:28

din zilele anterioare

GSK to buy US cancer treatment firm Nuvalent for $10.6bn https://www.theguardian.com - 09.06.2026 09:28